These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 10653869)

  • 21. Hematopoietic recovery after allogeneic blood stem-cell transplantation compared with bone marrow transplantation in patients with hematologic malignancies.
    Pavletic ZS; Bishop MR; Tarantolo SR; Martin-Algarra S; Bierman PJ; Vose JM; Reed EC; Gross TG; Kollath J; Nasrati K; Jackson JD; Armitage JO; Kessinger A
    J Clin Oncol; 1997 Apr; 15(4):1608-16. PubMed ID: 9193360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
    Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood versus marrow hematopoietic allogeneic graft.
    Robinet E; Lapierre V; Tayebi H; Kuentz M; Blaise D; Tiberghien P
    Transfus Apher Sci; 2003 Aug; 29(1):53-9. PubMed ID: 12877895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Economic analysis of a randomized clinical trial to compare filgrastim-mobilized peripheral-blood progenitor-cell transplantation and autologous bone marrow transplantation in patients with Hodgkin's and non-Hodgkin's lymphoma.
    Smith TJ; Hillner BE; Schmitz N; Linch DC; Dreger P; Goldstone AH; Boogaerts MA; Ferrant A; Link H; Zander A; Yanovich S; Kitchin R; Erder MH
    J Clin Oncol; 1997 Jan; 15(1):5-10. PubMed ID: 8996118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allogeneic bone marrow transplantation for chronic myeloid leukemia in childhood: a report from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).
    Millot F; Esperou H; Bordigoni P; Dalle JH; Michallet M; Michel G; Bourhis JL; Kuenz M; Blaise D; Garban F; Plouvier E; Rome A; Guilhot J; Guilhot F
    Bone Marrow Transplant; 2003 Nov; 32(10):993-9. PubMed ID: 14595387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Donor-recipient incompatibility at CD31-codon 563 is a major risk factor for acute graft-versus-host disease after allogeneic bone marrow transplantation from a human leucocyte antigen-matched donor.
    Balduini CL; Frassoni F; Noris P; Klersy C; Iannone AM; Bacigalupo A; Giorgiani G; Di Pumpo M; Locatelli F
    Br J Haematol; 2001 Sep; 114(4):951-3. PubMed ID: 11564091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative outcomes of T-cell-depleted and non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: impact of donor lymphocyte infusion.
    Sehn LH; Alyea EP; Weller E; Canning C; Lee S; Ritz J; Antin JH; Soiffer RJ
    J Clin Oncol; 1999 Feb; 17(2):561-8. PubMed ID: 10080600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of graft-versus-host disease as immunotherapy of leukemia relapsing after allogeneic transplantation: single-center experience of 32 adult patients.
    Mehta J; Powles R; Kulkarni S; Treleaven J; Singhal S
    Bone Marrow Transplant; 1997 Jul; 20(2):129-35. PubMed ID: 9244416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of unrelated cord blood transplantation and HLA-matched sibling hematopoietic stem cell transplantation for patients with chronic myeloid leukemia in advanced stage.
    Zheng C; Tang B; Yao W; Tong J; Zhu X; Song K; Geng L; Liu H; Sun Z
    Biol Blood Marrow Transplant; 2013 Dec; 19(12):1708-12. PubMed ID: 24060407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preliminary results of treatment with filgrastim for relapse of leukemia and myelodysplasia after allogeneic bone marrow transplantation.
    Giralt S; Escudier S; Kantarjian H; Deisseroth A; Freireich EJ; Andersson BS; O'Brien S; Andreeff M; Fisher H; Cork A
    N Engl J Med; 1993 Sep; 329(11):757-61. PubMed ID: 7688862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical study on haploid HLA-matched hematopoietic stem cell transplantation for treatment of malignant hematological disease].
    Sun AN; Wu DP; Wang Y; Qiu HY; Jin ZM; Miao M; Tang XW; Fu ZZ; Ma X; Han Y; He GS; Chen SN; Xue SL; Zhao Y
    Ai Zheng; 2006 Aug; 25(8):1019-22. PubMed ID: 16965686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The addition of allogeneic peripheral blood-derived progenitor cells to bone marrow for transplantation: results of a randomised clinical trial.
    Szer J; Curtis DJ; Bardy PG; Grigg AP
    Aust N Z J Med; 1999 Aug; 29(4):487-93. PubMed ID: 10868525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment with recombinant interferon (alpha-2b) early after bone marrow transplantation in patients at high risk for relapse [corrected].
    Klingemann HG; Grigg AP; Wilkie-Boyd K; Barnett MJ; Eaves AC; Reece DE; Shepherd JD; Phillips GL
    Blood; 1991 Dec; 78(12):3306-11. PubMed ID: 1742491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early allogeneic transplantation favorably influences the outcome of adult patients suffering from acute myeloid leukemia. Société Française de Greffe de Moelle (SFGM).
    Jourdan E; Maraninchi D; Reiffers J; Gluckman E; Rio B; Jouet JP; Michallet M; Molina L; Archimbaud E; Harousseau JL; Ifrah N; Attal M; Guilhot F; Kuentz M; Guyotat D; Pico JL; Dauriac C; Legros M; Dreyfus F; Bordigoni P; Leblond V; Gratecos N; Varet B; Auzanneau C; Blaise D
    Bone Marrow Transplant; 1997 May; 19(9):875-81. PubMed ID: 9156260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A retrospective comparison of allogeneic peripheral blood stem cell and bone marrow transplantation results from a single center: a focus on the incidence of graft-vs.-host disease and relapse.
    Ustün C; Arslan O; Beksaç M; Koç H; Gürman G; Ozçelik T; Yilmaz B; Ilhan O; Akan H; Ozcan M; Demirer T; Uysal A; Konuk N; Arat M; Dilek I; Celebi H; Coskun HS
    Biol Blood Marrow Transplant; 1999; 5(1):28-35. PubMed ID: 10232738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current thinking in the management of leukaemia.
    Szer J
    Aust Fam Physician; 1994 Aug; 23(8):1500-5. PubMed ID: 7526835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Peripheral blood stem cell transplantation for 53 patients with malignant hematologic diseases].
    Xie XS; Wan DM; Sun H; Sun L; Liu LX; Jiang ZX
    Ai Zheng; 2007 Apr; 26(4):403-6. PubMed ID: 17430661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allogeneic blood cell transplantation without posttransplant colony-stimulating factors in patients with hematopoietic neoplasm: a phase II study.
    Rosenfeld C; Collins R; Piñeiro L; Agura E; Nemunaitis J
    J Clin Oncol; 1996 Apr; 14(4):1314-9. PubMed ID: 8648389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Allogeneic hematopoietic transplantation with stem cells extracted from peripheral blood].
    Kusminsky G; Foncuberta MC; Aversa L; Drelichman G; Freigeiro D; Burgos R; Irrazabal C; Gonzalez G; Dictar M; Niborski R; Kohan A; Sanchez Avalos JC
    Medicina (B Aires); 2000; 60(2):179-87. PubMed ID: 10962806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term follow-up of recipients of allogeneic bone marrow grafts reveals no progressive telomere shortening and provides no evidence for haematopoietic stem cell exhaustion.
    de Pauw ES; Otto SA; Wijnen JT; Vossen JM; van Weel MH; Tanke HJ; Miedema F; Willemze R; Roelofs H; Fibbe WE
    Br J Haematol; 2002 Feb; 116(2):491-6. PubMed ID: 11841457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.